BIVV

Bioverativ Inc. Common Stock

$51.47 +$0.76 +1.48%



Shares Bought2
Shares Sold2
Total4
Shares Owned0
Last Price$51.47
Total Return-$1.85
Range Today$50.62 - $51.58
52 Week Range$40.00 - $64.41
Open$50.75
Market Cap$5.57B
Volume/Average746.89K/1.60M
P/E Ratio12.56
Dividend/Yield-




Bioverativ engages in discovery, research, development and commercialization of therapies for the treatment of hemophilia and other blood disorder. Its product includes Eloctate and Alprolix. The company is headquartered in Cambridge, MA.


Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
08-30-17 19:06 09-01-17 14:44 $56.15 $55.65 -$0.50 -0.89% kurt_woloch
08-29-17 21:00 09-01-17 14:35 $57.05 $55.70 -$1.35 -2.36% unholyurinal